Fairvalue-Calculator Fairvalue-Calculator
EN DE

Formosa Laboratories, Inc (4746) Fair Value & Analysis

Healthcare · TW · Market cap 6.2B TWD

Price52.60 TWD
Fair Value77.83 TWD
Upside+48.0%
Quality85/100
Evidence: Medium Range 49.41 TWD – 100.87 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Formosa Laboratories, Inc (4746) currently trades at 52.60 TWD, while our model-based Fair Value estimate is 77.83 TWD — implying the stock looks roughly 48.0% undervalued today. We read business quality at 85/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiotics, and other areas; and injectables in the areas of IDA, MRI agents, oncology, and others. The company also provides contract development and manufacturing services, including recrystallization, filtration, dialysis, column purification, distillation, spray drying, and micronization; injectable manufacturing and secondary packaging, labeling, and serialization services; custom fermentation services; and peptide synthesis services. In …

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1827% Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -81%

Frequently asked questions

Is Formosa Laboratories, Inc (4746) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 77.83 TWD versus a price of 52.60 TWD — about +48% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 4746?
Our 21-model fair value for Formosa Laboratories, Inc is 77.83 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 52.60 TWD.
What is the quality score of 4746?
Formosa Laboratories, Inc has a Quality Score of 85/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.